CompanyScope

Insmed Inc. revenue by year

Ticker INSM · SEC CIK 1104506 · Latest fiscal year ended Dec 31, 2025

Over the 10 fiscal years shown, revenue went from $0 (year ended Dec 31, 2016) to $606.42M (year ended Dec 31, 2025). The fastest growth was +1287.6% in the year ended Dec 31, 2019; the weakest year was +14.6% (year ended Dec 31, 2021).

$0$200M$400M$600M$800MDec 2016: $0Dec 2017: $0Dec 2018: $9.84MDec 2019: $136.47MDec 2020: $164.41MDec 2021: $188.46MDec 2022: $245.36MDec 2023: $305.21MDec 2024: $363.71MDec 2025: $606.42MDec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Insmed Inc. revenue by fiscal year, USD. Hover a bar for the exact figure.

Annual revenue

Fiscal year endedRevenue (USD)ChangeXBRL conceptReported in
Dec 31, 2025$606.42M+66.7%RevenueFromContractWithCustomerExcludingAssessedTax10-K filed Feb 19, 2026
Dec 31, 2024$363.71M+19.2%RevenueFromContractWithCustomerExcludingAssessedTax10-K filed Feb 19, 2026
Dec 31, 2023$305.21M+24.4%RevenueFromContractWithCustomerExcludingAssessedTax10-K filed Feb 19, 2026
Dec 31, 2022$245.36M+30.2%RevenueFromContractWithCustomerExcludingAssessedTax10-K filed Feb 20, 2025
Dec 31, 2021$188.46M+14.6%RevenueFromContractWithCustomerExcludingAssessedTax10-K filed Feb 22, 2024
Dec 31, 2020$164.41M+20.5%RevenueFromContractWithCustomerExcludingAssessedTax10-K filed Feb 23, 2023
Dec 31, 2019$136.47M+1287.6%RevenueFromContractWithCustomerExcludingAssessedTax10-K filed Feb 17, 2022
Dec 31, 2018$9.84M—RevenueFromContractWithCustomerExcludingAssessedTax10-K filed Feb 25, 2021
Dec 31, 2017$0—Revenues10-K filed Feb 23, 2018
Dec 31, 2016$0—Revenues10-K filed Feb 23, 2018

Insmed Inc. reported revenue under 2 different XBRL concepts across these years (often after the 2018 change in revenue-recognition rules, ASC 606). Each row shows the concept used, so you can judge comparability.

Quarterly revenue

Quarters reported in 10-Q filings. Fourth quarters are usually reported only inside the annual 10-K, so they are not listed separately here; we do not estimate them.

QuarterRevenue (USD)vs same quarter a year earlierSource
3 months ended Sep 30, 2026$524.43M+268.4%10-Q filed Oct 29, 2026
3 months ended Jun 30, 2026$425.49M+296.1%10-Q filed Aug 6, 2026
3 months ended Mar 31, 2026$305.96M+229.6%10-Q filed May 7, 2026
3 months ended Sep 30, 2025$142.34M+52.4%10-Q filed Oct 29, 2026
3 months ended Jun 30, 2025$107.42M+18.9%10-Q filed Aug 6, 2026
3 months ended Mar 31, 2025$92.82M+22.9%10-Q filed May 7, 2026
3 months ended Sep 30, 2024$93.42M+18.2%10-Q filed Oct 30, 2025
3 months ended Jun 30, 2024$90.34M+17.0%10-Q filed Aug 7, 2025

Source: SEC EDGAR XBRL company facts for CIK 1104506 (raw data). Most recent filing in this dataset: 10-Q filed Oct 29, 2026. SEC data file dated Nov 3, 2026; page built Nov 5, 2026. Figures are as most recently reported, including restatements. How we select figures.